Stunning cancer research: How modified citrus pectin blocks tumor growth

Stunning cancer research: How modified citrus pectin blocks tumor growth

(NaturalHealth365) Can modified citrus pectin affect the growth of cancer cells? And, if so (in a positive way), why isn’t this front page news?!  Let’s take a closer look.

Prostate cancer is currently the most common non-skin cancer among men in the United States, with over 172,000 men diagnosed with the disease in the year 2014 alone. Although prostate cancer carries a good prognosis (if caught in time), the odds of survival tumble to a grim one in three once the cancer has spread.

But, now, encouraging findings show that modified citrus pectin, or MCP, can inhibit the growth and metastasis of prostate cancer – impressing researchers and inspiring calls for further study. Honestly, we don’t expect the mainstream media to pick up this story – but, this news should not be ignored!

Modified citrus pectin impedes cancer growth in a fascinating way

Research has shown that a protein known as galectin-3 facilitates the growth of cancer. Although galectin-3 is needed in the body for tissue growth and repair, it can also be a “two-edged sword” that causes inflammation and encourages cancer to spread.

Specifically, the galectin-3 molecule allows cancer cells to bind together – and to adhere to the lining of blood vessels and other healthy tissue. Galectin-3 also promotes angiogenesis – the formation and development of new blood vessels that provide tumors with essential nutrients and oxygen – and helps cancer cells avoid apoptosis, or programmed cell death.

This is where modified citrus pectin, a water-soluble polysaccharide fiber, comes to the rescue.

Do NOT ignore the health dangers linked to toxic indoor air.  These chemicals - the 'off-gassing' of paints, mattresses, carpets and other home/office building materials - increase your risk of nasal congestion, fatigue, poor sleep, skin issues plus many other health issues.

Get the BEST indoor air purification system - at the LOWEST price, exclusively for NaturalHealth365 readers.  I, personally use this system in my home AND office.  Click HERE to order now - before the sale ends.

Although scientists have long known that citrus pectin has powerful beneficial effects, the substance isn’t readily absorbed into the bloodstream – a drawback that limits its usefulness. MCP is simply citrus pectin that has been modified to make it more easily available to the body.

MCP contains sugar molecules known as galactosides, which bind to galectin-3 and help to disable it – combating its cancer-promoting effects at every step of the way.

According to researchers, MCP has the potential to help treat cancers in which galectin-3 plays a role – including leukemia and cancers of the breast, colon, skin and lung.

Now, it’s time to EXPOSE what the studies reveal

A study published in Journal of the National Cancer Institute showed that MCP suppressed the growth of laboratory-induced tumors.

Mice that had been treated with MCP were injected with human breast cancer cells – and the results were encouraging. The tumors from the MCP-treated mice had one-third the amount of blood vessels per unit area – as compared to the tumors of the mice in the control group.

And, cell studies showed that MCP inhibited the binding of galectin-3 to human endothelial cells, while also suppressing the growth of capillary tubes. By the way, the studies weren’t limited to animals and cell cultures.

Two different clinical studies showed that MCP slowed the doubling time of prostate specific androgen, or PSA – demonstrating that the fiber could interfere with the spread of prostate cancer.

The men were treated with 15 grams per day of a MCP formulation known as Pecta-Sol. Not only did amounts of PSA double more slowly, but in some cases PSA levels – a measurement of cancer progression – actually dropped.

Bottom line: this data suggests that the MCP was reversing cancer by actively killing cancer cells!

MCP makes immune system cells more powerful

In a 2011 study published in BMC Complementary and Alternative Medicine, researchers found that MCP “very significantly” promoted and enhanced the activity of T-cytotoxic cells and natural killer cells against human leukemia cells.

The team commented on the “remarkable” increase in the immune cells’ power. In fact, the MCP increased the activation of the NK-cells by a stunning ten times – along with causing a 53.6 percent increase in the NK-cells’ ability to identify and destroy malignant cells.

Researchers lauded MCP as a powerful immune enhancing agent that could selectively increase cytotoxic immune activity against cancer and infections. Study lead Dr. Steve Melnick reported that the immune-stimulating effect of MCP was much greater than other substances studied – including medicinal mushrooms.

MCP helps to safely remove (cancer-causing) heavy metals from the body

MCP targets cancer in yet another way – by binding to and helping to eliminate toxic heavy metals such as arsenic, lead, mercury and cadmium.

In one study, participants took 15 grams of Pecta-Sol for five days, followed by 20 grams on the sixth day. Urinary levels of arsenic, mercury, lead and cadmium rose significantly, showing that the toxins were being eliminated from the body.

The World Health Organization’s International Agency for Research on Cancer classifies cadmium as a known human carcinogen that has been linked to cancers of the lung, prostate and genitourinary system. And mercury, lead and arsenic increase oxidative stress and stimulate the production of pro-inflammatory substances – which tends to promote cancer growth, as well.

MCP’s ability to rid the body of these dangerous heavy metals – while causing no adverse effects – is yet another anticancer “feather in the cap” of this protective nutrient.

According to Dr. Isaac Eliaz, an integrative medical doctor and leading MCP researcher, the safety and effectiveness of modified citrus pectin can’t be overstated.

“MCP is one of the most important nutrients,” Dr. Eliaz declares, “in the fight against cancer.”

Sources for this article include:

Notify of
Inline Feedbacks
View all comments